Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Heather J. Duncan"'
Autor:
Adeboye A Adejare, Heather J Duncan, R Geoffrey Motz, Silvi Shah, Charuhas V Thakar, Mark H Eckman
Publikováno v:
JMIR Formative Research, Vol 6, Iss 7, p e33562 (2022)
BackgroundPatients with end-stage kidney disease (ESKD) wait roughly 4 years for a kidney transplant. A potential way to reduce wait times is using hepatitis C virus (HCV)–viremic kidneys. ObjectiveAs preparation for developing a shared decision-m
Externí odkaz:
https://doaj.org/article/1bef26c115cd44779e1298aeb87b110b
Autor:
Adeboye A Adejare, Heather J Duncan, R Geoffrey Motz, Silvi Shah, Charuhas V Thakar, Mark H Eckman
Publikováno v:
JMIR formative research. 6(7)
Background Patients with end-stage kidney disease (ESKD) wait roughly 4 years for a kidney transplant. A potential way to reduce wait times is using hepatitis C virus (HCV)–viremic kidneys. Objective As preparation for developing a shared decision-
Autor:
Adeboye A Adejare Jr, Heather J Duncan, Geoffrey R. Motz, Silvi Shah, Charuhas V. Thakar, Mark H. Eckman
BACKGROUND Background: Patients with End-Stage Kidney Disease (ESKD) wait roughly 4 years for a kidney transplant. A potential way to reduce wait times is through the use of Hepatitis-C Viremic (HCV) kidneys. OBJECTIVE Objective: As preparation for d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9afb2258ecdb3798895655ad086c4234
https://doi.org/10.2196/preprints.33562
https://doi.org/10.2196/preprints.33562
Autor:
Heather J. Duncan, Adeboye A. Adejare, Kenneth E. Sherman, Mark H. Eckman, Rita R. Alloway, E. Steve Woodle, Charuhas V. Thakar
Publikováno v:
MDM Policy & Practice, Vol 6 (2021)
MDM Policy & Practice
MDM Policy & Practice
Introduction. While use of (hepatitis C virus) HCV-viremic kidneys may result in net benefit for the average end-stage kidney disease (ESKD) patient awaiting transplantation, patients may have different values for ESKD-related health states. Thus, th
Publikováno v:
The Journal of Immunology. 202:132.8-132.8
Lupus nephritis (LN) occurs in up to 60% of patients with systemic lupus erythematosus (SLE) and it remains the predominant cause of morbidity and mortality. Current available therapies for SLE have serious side effects and limited efficacy. Our rese
Autor:
Murad Melhem, Ashwath Narayana, Prabir Roy-Chaudhury, Sue C. Heffelfinger, Burnett S. Kelly, Jianhua Zhang, Heather J. Duncan, Pankaj B. Desai
Publikováno v:
Blood Purification. 21:99-110
Hemodialysis vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population at a cost of over USD 1 billion per annum. Most hemodialysis grafts fail due to a venous stenosis (venous neointimal hyperplasia
Publikováno v:
The American Journal of the Medical Sciences. 323:210-215
Parathyroid hormone (PTH) suppression in patients with end-stage renal disease (ESRD) undergoing maintenance hemodialysis is achieved largely by the use of intravenous calcitriol. Aspects of the utility and efficacy of this therapy remain controversi
Publikováno v:
The Laryngoscope. 108:508-513
As the field of sleep medicine has evolved, the clinical implications of obstructive sleep apnea (OSA) in snoring patients have become well accepted. Recent advances in surgical therapy for snoring allow otolaryngologists to offer simple outpatient t
Autor:
Shashi K. Kant, Prabir Roy-Chaudhury, Darryl A. Zuckerman, Ashwatha Narayana, Rino Munda, Heather J. Duncan, Burnett S. Kelly, Rashid Faiyaz
Publikováno v:
The journal of vascular access. 13(3)
Purpose The aim of this study was to identify the effects of external beam radiation on PTFE dialysis graft dysfunction. Methods Seven patients who underwent PTFE dialysis graft angioplasty were randomized to receive either two 8 Gy doses of external
Publikováno v:
Physiology & Behavior. 52:617-620
In investigating the ability of the rat to discriminate among urine odors from mice of different genetic strains, we developed a technique for determining the extent of odor generalization. Trained rats performed a discrete trial, go/no-go procedure,